Open-SESAME OPENing biological barriers using Shell-Engineered Shape-Adaptable Microbubble Enhancers
- Coordinator
- Universitaetsklinikum Aachen, Germany
- Runs
- 1 October 2025 to 31 March 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101247604
What the project is doing
In the project's own words, from its summary on CORDIS.
OPEN-SESAME will assess the technical and commercial feasibility of a modular microbubble platform technology to enhance the delivery of drugs across biological barriers. The project aims to: (i) establish a robust and scalable synthesis protocol for producing shell- and shape-optimized polymeric microbubbles; (ii) evaluate the preclinical performance of our ultrasound-responsive microbubble enhancers in brain and tumor mouse models; (iii) strengthen our intellectual property (IP) position through freedom-to-operate investigation and generation of new IP on microbubble functionalization; (iv) consult key opinion leaders and perform market analysis of the drug therapy enhancer landscape; and (v) consolidate results in an investor-ready business plan to guide the commercialization of our microbubble platform.
We anticipate that by exploiting the technological and socio-economic potential identified in the OPEN-SESAME project, we will create completely new opportunities for the use of microbubbles plus ultrasound to enhance drug delivery and improve therapy outcomes in patients suffering from high-medical-need diseases.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitaetsklinikum Aachen | Aachen | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI